Frontier Biotechnologies Inc. (SHA:688221)

Frontier Biotechnologies Statistics

Total Valuation

SHA:688221 has a market cap or net worth of CNY 8.06 billion. The enterprise value is 7.74 billion.

Market Cap	8.06B
Enterprise Value	7.74B

Important Dates

The next estimated earnings date is Tuesday, March 31, 2026.

Earnings Date	Mar 31, 2026
Ex-Dividend Date	n/a

Share Statistics

SHA:688221 has 374.58 million shares outstanding. The number of shares has decreased by -0.12% in one year.

Current Share Class	374.58M
Shares Outstanding	374.58M
Shares Change (YoY)	-0.12%
Shares Change (QoQ)	-3.96%
Owned by Insiders (%)	16.08%
Owned by Institutions (%)	0.10%
Float	211.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	57.06
PB Ratio	8.21
P/TBV Ratio	9.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-46.14
EV / Sales	54.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-35.48

Financial Position

The company has a current ratio of 2.70, with a Debt / Equity ratio of 0.38.

Current Ratio	2.70
Quick Ratio	2.50
Debt / Equity	0.38
Debt / EBITDA	n/a
Debt / FCF	-1.72
Interest Coverage	-29.42

Financial Efficiency

Return on equity (ROE) is -15.74% and return on invested capital (ROIC) is -11.53%.

Return on Equity (ROE)	-15.74%
Return on Assets (ROA)	-9.35%
Return on Invested Capital (ROIC)	-11.53%
Return on Capital Employed (ROCE)	-21.84%
Weighted Average Cost of Capital (WACC)	9.17%
Revenue Per Employee	467,560
Profits Per Employee	-555,409
Employee Count	524
Asset Turnover	0.08
Inventory Turnover	1.90

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +122.89% in the last 52 weeks. The beta is 0.96, so SHA:688221's price volatility has been similar to the market average.

Beta (5Y)	0.96
52-Week Price Change	+122.89%
50-Day Moving Average	21.83
200-Day Moving Average	16.10
Relative Strength Index (RSI)	40.39
Average Volume (20 Days)	18,224,710

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688221 had revenue of CNY 141.20 million and -167.73 million in losses. Loss per share was -0.45.

Revenue	141.20M
Gross Profit	39.17M
Operating Income	-272.37M
Pretax Income	-167.73M
Net Income	-167.73M
EBITDA	-268.43M
EBIT	-272.37M
Loss Per Share	-0.45

Balance Sheet

The company has 692.14 million in cash and 374.34 million in debt, with a net cash position of 317.80 million or 0.85 per share.

Cash & Cash Equivalents	692.14M
Total Debt	374.34M
Net Cash	317.80M
Net Cash Per Share	0.85
Equity (Book Value)	981.52M
Book Value Per Share	2.62
Working Capital	665.48M

Cash Flow

In the last 12 months, operating cash flow was -190.38 million and capital expenditures -27.73 million, giving a free cash flow of -218.11 million.

Operating Cash Flow	-190.38M
Capital Expenditures	-27.73M
Free Cash Flow	-218.11M
FCF Per Share	-0.58

Margins

Gross margin is 27.74%, with operating and profit margins of -192.90% and -118.79%.

Gross Margin	27.74%
Operating Margin	-192.90%
Pretax Margin	-118.79%
Profit Margin	-118.79%
EBITDA Margin	-190.10%
EBIT Margin	-192.90%
FCF Margin	n/a

Dividends & Yields

SHA:688221 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.12%
Shareholder Yield	0.12%
Earnings Yield	-2.08%
FCF Yield	-2.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SHA:688221 has an Altman Z-Score of 2.08 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.08
Piotroski F-Score	2